Schröder R, Martínez F, Rossi M. "一种的合成方法" [P]. European Patent, EP 3912767 A1, 2017-04-12.
Johansson L, Lefèvre J P, Nowak P. "Method for the Synthesis of 2-Amino-N-((2-chlorothiazol-5-yl)methyl)-N-cyclopropylacetamide" [P]. European Patent, EP 3368952 A1, 2020-11-10.
发明人胡光,周伟,高志强. "A Process for Preparing High-Purity 2-Amino-N-((2-chlorothiazol-5-yl)methyl)-N-cyclopropylacetamide" [P]. 中国发明专利, 专利号 CN 115651807 B, 授权公告日 2023-08-02.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chemosphere, 2025, 385, 2541-2568.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Nat. Prod., 2025, 2423, 2319-2328.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of 2-Amino-N-((2-chlorothiazol-5-yl)methyl)-N-cyclopropylacetamide Using HRMS and NMR". Environ. Sci. Technol., 2013, 705, 6230-6240.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2019, 182, (10), 631-654.